Friday, March 08, 2024 2:31:58 PM
Israeli stonks are notorious for pump and dumps
A pump will begin two nanoseconds after the moomoo session opens for orders at 4am when it’s 11am in Tel Aviv
How long the pump lasts varies
Others may disagree with what I think is the usual senario for Israeli stonks
QNRX was done well before the 7am platforms open for orders
Sometimes the pump can continue after 7am when it’s 2pm in Tel Aviv
Most times, though put a for in it it’s done and the Tel Aviv players go out for dinner
A pump will begin two nanoseconds after the moomoo session opens for orders at 4am when it’s 11am in Tel Aviv
How long the pump lasts varies
Others may disagree with what I think is the usual senario for Israeli stonks
QNRX was done well before the 7am platforms open for orders
Sometimes the pump can continue after 7am when it’s 2pm in Tel Aviv
Most times, though put a for in it it’s done and the Tel Aviv players go out for dinner
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent QNRX News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 08:38:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 01:35:33 PM
- Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results • GlobeNewswire Inc. • 03/26/2026 12:30:00 PM
- Quoin advances QRX003 development after positive FDA meeting on Netherton syndrome • IH Market News • 03/25/2026 03:07:12 PM
- Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome • GlobeNewswire Inc. • 03/25/2026 12:30:00 PM
- Quoin Pharmaceuticals to Announce Corporate Update and Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 26, 2026 • GlobeNewswire Inc. • 03/19/2026 12:30:00 PM
- Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome • GlobeNewswire Inc. • 03/11/2026 12:30:00 PM
- NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome • GlobeNewswire Inc. • 02/26/2026 01:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/18/2026 01:14:32 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/17/2026 08:20:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 10:24:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 10:20:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 10:18:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 10:17:29 PM
- Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 10:18:14 PM
- Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome • GlobeNewswire Inc. • 01/20/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/05/2025 01:00:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/03/2025 10:39:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2025 10:00:56 PM
